United States In Vitro Diagnostics Market Snapshot
The US IVD market is expected to grow moderately, supported by rising rates of chronic and infectious conditions, a growing elderly population, and the ongoing transition to valuebased care. These factors will accelerate the adoption of innovative assays and novel IVD platforms designed to enhance diagnostic precision and shorten processing times.
Read our Market Snapshot to access comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2035.
